If a director is willing to pay 7 cents per share for a loan when the open market shares are around 3 cents then l too agree that the company is definitely undervalued.
Furthermore, when the MOU is formalised and binding then NSP's share price is likely to be a minimum 10 cents. A realistic valuation is more likely in excess of 20 milllion.
I am a shareholder who has accumulated heavily in recent times and will not be selling my shares. As you say Michelin Man, this company has a real chance of transistioning to a successful dividend bearing company. The Health Sector is one of the most favoured at present and NSP is extremely well positioned going into vast markets which need innovation and advancements in health related products and services.
In summary, if John Manusa and the team secure the 20 million, then the share price will go north, north and north.
MEM Price at posting:
5.1¢ Sentiment: Buy Disclosure: Held
